These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15099346)

  • 1. Association between -250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population.
    de Andrade FM; Silveira FR; Arsand M; Antunes AL; Torres MR; Zago AJ; Callegari-Jaques SM; Hutz MH
    Clin Genet; 2004 May; 65(5):390-5. PubMed ID: 15099346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese.
    Ko YL; Hsu LA; Hsu KH; Ko YH; Lee YS
    Atherosclerosis; 2004 Jan; 172(1):135-42. PubMed ID: 14709367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans.
    Park KW; Choi JH; Chae IH; Cho HJ; Oh S; Kim HS; Lee MM; Park YB; Choi YS
    J Biochem Mol Biol; 2003 Mar; 36(2):237-42. PubMed ID: 12689525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 584C/T polymorphism in endothelial lipase gene with risk of coronary artery disease.
    Elnaggar IZ; Hussein S; Amin MI; Abdelaziz EA
    J Cell Biochem; 2019 Sep; 120(9):14414-14420. PubMed ID: 31020688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
    Meng L; Ruixing Y; Yiyang L; Xingjiang L; Kela L; Wanying L; Lin Z; Weixiong L; Dezhai Y; Shangling P
    Lipids Health Dis; 2010 Mar; 9():28. PubMed ID: 20222961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
    Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
    Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rs2070895 (-250G/A) Single Nucleotide Polymorphism in Hepatic Lipase (HL) Gene and the Risk of Coronary Artery Disease in North Indian Population: A Case-Control Study.
    Verma P; Verma DK; Sethi R; Singh S; Krishna A
    J Clin Diagn Res; 2016 Aug; 10(8):GC01-6. PubMed ID: 27656463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of endothelial lipase gene related single nucleotide polymorphisms in patients with coronary artery disease.
    Abudureyimu S; Abulaiti P; Li H; Xing Z; Liu S; Li W; Gao Y
    Gene; 2021 Jul; 788():145669. PubMed ID: 33882321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study.
    Couture P; Otvos JD; Cupples LA; Lahoz C; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):815-22. PubMed ID: 10712408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
    Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
    Zambon A; Deeb SS; Hokanson JE; Brown BG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1723-9. PubMed ID: 9812910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of endothelial lipase gene-384A/C with coronary artery disease in Han Chinese people.
    Xie L; Sun Y; Tong Y; Liu Y; Deng Y
    BMJ Open; 2015 Jun; 5(6):e007621. PubMed ID: 26124511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
    Shohet RV; Vega GL; Anwar A; Cigarroa JE; Grundy SM; Cohen JC
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1975-8. PubMed ID: 10446080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
    Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
    J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.